375 related articles for article (PubMed ID: 25728938)
1. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
3. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
[TBL] [Abstract][Full Text] [Related]
4. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD
Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969
[TBL] [Abstract][Full Text] [Related]
5. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.
Karamanou K; Franchi M; Piperigkou Z; Perreau C; Maquart FX; Vynios DH; Brézillon S
Sci Rep; 2017 Mar; 7():45138. PubMed ID: 28332606
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.
Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK
Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695
[TBL] [Abstract][Full Text] [Related]
7. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
8. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism.
Zielinska HA; Holly JMP; Bahl A; Perks CM
Cancer Lett; 2018 Apr; 419():187-202. PubMed ID: 29331414
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.
Karamanou K; Franchi M; Vynios D; Brézillon S
Semin Cancer Biol; 2020 May; 62():125-133. PubMed ID: 31401293
[TBL] [Abstract][Full Text] [Related]
11. p53 inactivation decreases dependence on estrogen/ERK signalling for proliferation but promotes EMT and susceptility to 3-bromopyruvate in ERα+ breast cancer MCF-7 cells.
Rieber M; Strasberg-Rieber M
Biochem Pharmacol; 2014 Mar; 88(2):169-77. PubMed ID: 24486524
[TBL] [Abstract][Full Text] [Related]
12. Sulfated Hyaluronan Modulates the Functional Properties and Matrix Effectors Expression of Breast Cancer Cells with Different Estrogen Receptor Status.
Koutsakis C; Tavianatou AG; Kokoretsis D; Baroutas G; Karamanos NK
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944559
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
14. Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells.
Huderson BP; Duplessis TT; Williams CC; Seger HC; Marsden CG; Pouey KJ; Hill SM; Rowan BG
Endocrinology; 2012 Sep; 153(9):4144-59. PubMed ID: 22733972
[TBL] [Abstract][Full Text] [Related]
15. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer.
Miano V; Ferrero G; Reineri S; Caizzi L; Annaratone L; Ricci L; Cutrupi S; Castellano I; Cordero F; De Bortoli M
Oncotarget; 2016 Jan; 7(3):3201-16. PubMed ID: 26621851
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
17. First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrix.
Epstein Shochet G; Drucker L; Pomeranz M; Fishman A; Pasmanik-Chor M; Tartakover-Matalon S; Lishner M
Mol Carcinog; 2017 Jan; 56(1):62-74. PubMed ID: 26859229
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
[TBL] [Abstract][Full Text] [Related]
19. Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation.
Yang KM; Jung Y; Lee JM; Kim W; Cho JK; Jeong J; Kim SJ
Cancer Res; 2013 Nov; 73(22):6679-89. PubMed ID: 24062311
[TBL] [Abstract][Full Text] [Related]
20. IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules.
Afratis NA; Bouris P; Skandalis SS; Multhaupt HA; Couchman JR; Theocharis AD; Karamanos NK
Sci Rep; 2017 Jan; 7():40138. PubMed ID: 28079144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
